Navigation Links
Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
Date:5/23/2008

SAN DIEGO, May 23 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will Web cast its Annual Meeting of Stockholders on Friday, May 30, 2008 at 11:00 a.m. PT from the company's corporate headquarters in San Diego, CA. Following the Annual Meeting, Daniel M. Bradbury, President and Chief Executive Officer of Amylin Pharmaceuticals, will be providing a corporate overview.

The live presentation will be Web cast, and a recording will be made available following the event. The Web cast and recording will be accessible through Amylin's corporate Web site, located at http://www.amylin.com. To access the live Web cast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first- in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California with over 1,900 employees nationwide. Further information on Amylin Pharmaceuticals is available at http://www.amylin.com.


'/>"/>
SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
2. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
3. Amylin Pharmaceuticals Reports Third Quarter Financial Results
4. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
5. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
6. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
7. Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program
8. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amylin Pharmaceuticals to Webcast First Quarter Results
10. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
11. Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...rate research of potential vaccine for low-resourc...Md., Dec. 4 The biotech company Le... organization PATH announced today a partnership t...ine. PATH will initially invest $3 million over 27...lopment of a H5N1 virus-like particle (VLP) protot...
(Date:12/4/2008)...swire-FirstCall/ -- NeoStem, Inc.,(NYSE Alternext...lection,processing and long-term storage of adul...nced that it has reached a major milestone in its ...st ever collection center for collection of,adult...al need in New York,City and has chosen Bruce Yaf...
(Date:12/4/2008)...c. 4 A 60-year-old,pros...e first person in France,to be treated using Rapi...NYSE: VAR ) for fast and precise forms of intens...eatments at the CRLC Val D,Aurelle - Paul Lamarque...faster than conventional IMRT,treatments. Dr. Pas...
(Date:12/4/2008)...s New Trade Name Onrigin(TM) for Laromustine , ...ll/ -- VION PHARMACEUTICALS, INC. (OTC Bulletin B...ted to events in connection with the 50th American...ne Center in San Francisco from December 6-9, 2008..., The Company announced that it would present s...
Breaking Biology Technology:Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 2Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 3NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 2NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 3NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 4Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varian's RapidArc(TM) Radiotherapy 2Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varian's RapidArc(TM) Radiotherapy 3Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 2Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 3Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 4
... was developed at the USDA Forest Products Laborat...ison has been acquired by Xethanol Corp. of New ...TI), was a wholly owned subsidiary of UTEK Corp.,...thanol Corp. is a biotechnology-driven ethanol pro...rough a stock-for-stock exchange. , ,XTI holds a l...
...earch team announced on Sunday they have successfu...in cells, a finding that could affect some of the ...h avenues. But a University of Wisconsin-Madison p...d repercussions. , ,In an article published on the...rchers Chad Cowan, Kevin Eggan and their colleague...
...s made significant progress in improving business ...elieve investment restrictions if the state is to ...te Senate committee heard on Tuesday. , ,"Today it...y than it is to invest in emerging, growth Wiscons...private banker who formerly worked for the Wiscons...
... new UW E-Business Consortium member spotlight ser...y of Wisconsin E-Business Consortium in 2002. , ,...ciate creative appliance design. The brand those v...-Zero Freezer Co. , ,Sub-Zero,s built-in refriger...a home,s dcor, allowing customization to be driven...
Other Biology Technology:Harvard advance improves stem cell research; not a medical revolution 2Regulations still stymie business investment in high-growth companies 2Regulations still stymie business investment in high-growth companies 3Regulations still stymie business investment in high-growth companies 4How Sub-Zero Freezer Co. uses technology to revolutionize customer service 2How Sub-Zero Freezer Co. uses technology to revolutionize customer service 3
(Date:12/3/2008)...R 1, 2008 -- As the United States continues to dev...nergy independence, cellulosic-based ethanol has e...nologies. Corn stover remains the most popular sou... (SOC) associated with the removal of corn fodder ...al and environmental concern. , In the Novembe...
(Date:12/3/2008)...em of children failing to take their medication fo...ackled as part of a new university research projec...ists at The University of Nottingham and The Unive... school children with asthma, diabetes, congenital...riers that prevent them from taking medicines pres...
(Date:12/3/2008)...team of investigators led by researchers at the Ke...n California (USC) has received $19 million in fun... (NIMH) for a groundbreaking effort to collect gen...in order to study the genetic risks for schizophre...Genomic Psychiatry and Massachusetts General Hospi...
(Date:12/3/2008)...E, Mass. Natural changes in voltage that occur ac...powerful controlling factor in the process by whic...earch published by Tufts University scientists. ,...ssor of Biology Michael Levin, and Chair of Biomed...thor) published their paper "Membrane Potential C...
Breaking Biology News(10 mins):Managing carbon loss 2A spoonful of sugar? 2A spoonful of sugar? 3USC researchers head global effort to study genetic risks that contribute to psychiatric diseases 2USC researchers head global effort to study genetic risks that contribute to psychiatric diseases 3New 'control knobs' for stem cells identified 2XTL Biopharmaceuticals to Present at the Rodman 26 Renshaw 5th Annual Global Healthcare Conference 5422 1XTL Biopharmaceuticals to Present at the Rodman 26 Renshaw 5th Annual Global Healthcare Conference 5422 2Going barefoot 3F Beware 21 19426 1Going barefoot 3F Beware 21 19426 2After Effects 3A Giving Back Is Good for You 19422 1After Effects 3A Giving Back Is Good for You 19422 2Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention Deficit Hyperactivity Disorder 28ADHD 29 2070 1Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention Deficit Hyperactivity Disorder 28ADHD 29 2070 2Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention Deficit Hyperactivity Disorder 28ADHD 29 2070 3
...such as the Amazon rainforest are home to some 750...5 species in Britain. UCL scientists have ruled ou...of wildlife to climate change, in a paper publishe...e Royal Society B (Biological Sciences). , Instea...eater role in the evolution of species than extern...
...ring an ordinary half-hour argument is enough to s...t least one day, a new study has shown. , Moreove...le toward each other, the delay in that healing pr...dy have major financial implications for medical c..., reported in the current issue of the Archives of...
...tumors by selectively targeting and killing the ma...in the open access journal PLoS Medicine, has appl... (GBM). This is the most aggressive form of brain ...xperienced and killing most patients within a year...zki and colleagues (of The Hebrew University of Je...
...,s AURA satellite, determined the seasonal ozone h...aller than in previous years. , NASA,s 2005 asses... was the first based on observations from the Ozon...craft. Aura was launched in 2004. , This year,s o... peak between September and mid-October, which was...
Other Biology News:Why the Amazon rainforest is so rich in species 2Why the Amazon rainforest is so rich in species 3Stress substantially slows human body's ability to heal 2Stress substantially slows human body's ability to heal 3Preclinical study of a new brain tumor therapy 2NASA's AURA satellite peers into Earth's ozone hole 2
Luminometers
Prolong Gold Antifade Reagent from Invitrogen
Cell Lysis Buffer is used to lyse cells under nondenaturing conditions.
LECHNER AND LaVECK MEDIUMfor the clonal growth of normal human bronchial and other epithelial cells. Requires additives. With glutamine.Recommended storage condition:oC to 8oCIntended use(s):research
Biology Products: